EC
EcoR1 Capital Portfolio holdings
AUM
$1.69B
This Quarter Return
+31.56%
1 Year Return
+7.54%
3 Year Return
+113.08%
5 Year Return
+306.58%
10 Year Return
+4,328.75%
AUM
$3.85B
AUM Growth
+$3.85B
(+31%)
Cap. Flow
+$284M
Cap. Flow
% of AUM
7.37%
Top 10 Holdings %
Top 10 Hldgs %
72.18%
Holding
59
New
10
Increased
9
Reduced
4
Closed
8
Top Buys
| 1 |
argenx
ARGX
|
$115M |
| 2 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$96.9M |
| 3 |
Sarepta Therapeutics
SRPT
|
$80.3M |
| 4 |
Jazz Pharmaceuticals
JAZZ
|
$79.4M |
| 5 |
Arvinas
ARVN
|
$51.8M |
Top Sells
| 1 |
Revolution Medicines
RVMD
|
$156M |
| 2 |
SWTX
SpringWorks Therapeutics
SWTX
|
$80M |
| 3 |
MORF
Morphic Holding, Inc. Common Stock
MORF
|
$36.6M |
| 4 |
Relay Therapeutics
RLAY
|
$35M |
| 5 |
SLRN
ACELYRIN
SLRN
|
$14.3M |
Sector Composition
| 1 | Healthcare | 99.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CMAXW
51
DELISTED
CareMax, Inc. Warrant
CMAXW
| $49.8K | ﹤0.01% |
100,000
| – | – |
|
|
DCPH
52
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| – | – |
-993,000
| Closed | -$12.6M |
|
53
Tempest Therapeutics
TPST
$46.6M
| – | – |
-931,000
| Closed | -$284K |
|
|
SWTX
54
DELISTED
SpringWorks Therapeutics
SWTX
| – | – |
-3,460,208
| Closed | -$80M |
|
|
SLRN
55
DELISTED
ACELYRIN
SLRN
| – | – |
-1,402,201
| Closed | -$14.3M |
|
|
56
Relay Therapeutics
RLAY
$709M
| – | – |
-4,163,824
| Closed | -$35M |
|
57
Prime Medicine
PRME
$595M
| – | – |
-600,000
| Closed | -$5.72M |
|
58
Prelude Therapeutics
PRLD
$69.1M
| – | – |
-1,157,452
| Closed | -$3.58M |
|
59
Allogene Therapeutics
ALLO
$249M
| – | – |
-4,488,200
| Closed | -$14.2M |
|